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Abstract: Today, none of the wound dressings available on the market is fully capable of reproducing
all the features of native skin. Herein, an asymmetric electrospun membrane was produced to mimic
both layers of skin. It comprises a top dense layer (manufactured with polycaprolactone) that was
designed to provide mechanical support to the wound and a bottom porous layer (composed of
chitosan and Aloe Vera) aimed to improve the bactericidal activity of the membrane and ultimately the
healing process. The results obtained revealed that the produced asymmetric membranes displayed
a porosity, wettability, as well as mechanical properties similar to those presented by the native
skin. Fibroblast cells were able to adhere, spread, and proliferate on the surface of the membranes
and the intrinsic structure of the two layers of the membrane is capable of avoiding the invasion
of microorganisms while conferring bioactive properties. Such data reveals the potential of these
asymmetric membranes, in the near future, to be applied as wound dressings.
Keywords: Aloe Vera; asymmetric membranes; chitosan; electrospinning; wound dressings
1. Introduction
Skin structure and functions are often compromised by traumatic events (e.g., thermal burns, cuts,
lacerations or surgical incisions) or chronic wounds (e.g., pressure ulcers or diabetic foot ulcers) [1–4].
When a large area of skin is lost, the immediate coverage of the wound is mandatory for avoiding
water/blood losses, for preventing bacterial invasion, as well as decreasing the pain felt by patients [5].
Currently, autologous skin grafting remains the “gold standard” treatment used in the clinic.
However, this approach cannot always be used due to the extent of the wound, limited availability
of donor sites, scar formation, slow healing, and patient morbidity. Allogeneic and xenogeneic skin
grafts are alternative therapeutic approaches that have been also used, although their application
has associated risks of immune rejection, disease transmission, and limited availability of skin bank
collection [6,7]. To overcome these limitations, researchers have developed different skin substitutes,
some of them used in the clinic. Nevertheless, none of these skin substitutes is fully capable of
reestablishing the native structure and functions of skin [8,9].
Among the skin substitutes developed so far, asymmetric membranes to be applied as wound
dressings systems [10–13] have captured the attention of researchers. The top layer of these membranes
can be designed to avoid bacterial invasion and also prevent wound surface dehydration, whereas the
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underlying layer can be conceived to remove the wound exudate and to promote cell infiltration and
proliferation [8].
Heretofore, dry/wet and scCO2-induced phase inversion methods have been the most used to
produce asymmetric membranes [14,15]. In recent times, electrospinning emerged as an alternative
to produce bilayer membranes aimed to improve the healing process [16]. To produce electrospun
membranes, a charged polymer solution is initially accelerated under a high-voltage electrostatic field,
and subsequently, the fiber jet travels through the atmosphere to allow solvent evaporation, leading to
the deposition of solid polymer fibers on the collector. The produced fibers display a high surface to
volume ratio and porosity, properties that are crucial for increasing cell adhesion, growth, migration,
differentiation, and angiogenesis [17–19].
Herein, an asymmetric membrane, composed of two distinct layers (aimed to reproduce the
epidermis and dermis layers of skin), was produced through electrospinning. A synthetic polymer,
polycaprolactone (PCL), was used to produce the top layer that is aimed to act as a protective
barrier [13,20]. On the other hand, Chitosan (CS) and Aloe Vera (AV) were used to manufacture
the bottom layer. CS is a natural polysaccharide, known for its capacity of promoting collagen
synthesis and also by exhibiting bactericidal and hemostatic properties. Such features triggered its
use in the production of wound dressings, namely in HidroKi®, Patch®, Chitopack®, Tegasorb®, and
KytoCel® [16,21–25]. Although, limited solubility of CS at physiological pH and high viscosity in acid
solutions hinder its application in electrospinning. To overcome such a drawback, synthetic polymers
such as Poly(ethylene oxide) (PEO), Polyvinyl alcohol (PVA), Poly(lactide-co-glycolide) (PLGA) have
been blended with this polymer to enable the production of CS nanofibers [26–30]. AV is a member of
the Liliaceae family and it has been widely used for the treatment of different skin disorders, like burns,
infections, and other dermatologic conditions [31]. The mucilaginous gel, present in AV leaves, has
a higher water content (~99%), which is fundamental for wound hydration. Furthermore, different
compounds like amino acids, salicylic acid, ascorbic acid, vitamin A, and vitamin E are also found in
AV. Such biomolecules are responsible for conferring antibacterial, anti-inflammatory, and antioxidant
properties to AV [31–33]. In addition, AV is also known for, promoting fibroblast proliferation,
increasing collagen synthesis, and ultimately, enhancing the wound healing process [31–37].
2. Experimental Section
2.1. Materials
AV leaves were obtained from 5-year-old plants (Aloe barbadensis Miller) that were bought
from a Portuguese botanic shop. 3,3,3 Trifluoroethanol (TFE) was purchased from Acros Organics
(Jersey City, NJ, USA). Lysozyme from chicken egg was acquired from Alfa Aesar (Haverhill,
MA, USA). Fetal bovine serum (FBS) (free from any antibiotic) was purchased from Biochrom
AG (Berlin, Germany). Glacial acetic acid (AA) was obtained from LabChem (New York, NY,
USA). Paraformaldehyde (PFA) was obtained from Merck, SA (Algés, Portugal). Normal Human
Dermal Fibroblasts (NHDF) cells were purchased from PromoCell (Labclinics, S.A., Barcelona, Spain).
3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2 (4-sulfophenyl)-2H-tetrazolium (MTS)
was bought from Promega (Madison, WI, USA). Amphotericin B, CS (low molecular weight (LMW:
50,000–190,000 Da), Dulbecco’s modified Eagle’s medium (DMEM-F12), Ethylenediaminetetraacetic
acid (EDTA), Gentamicin, Glutaraldehyde, Kanamycin, LB Broth, Phosphate-buffered saline
solution (PBS), PCL (80,000 Da), PEO, Sodium hydroxide (NaOH) and Trypsin were acquired
from Sigma-Aldrich (Sintra, Portugal). Quant-iT Pico Green dsDNA assay kit was obtained from
ThermoFisher Scientific (Waltham, MA, USA). Bovine serum albumin was obtained from VWR
International (Carnaxide, Portugal). Staphylococcus aureus clinical isolate (S. aureus) ATCC 25923
and Escherichia Coli DH5α (E. coli) were used as models of prokaryotic organisms to evaluate the
bactericidal activity of the membranes.
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2.2. Methods
2.2.1. Extraction of the AV Gel
The extraction of AV gel was performed according to a method previously described elsewhere [34,35].
Briefly, AV leaves were initially washed with distilled water to remove any dirt from their surface and,
subsequently, the skin of the leaf was carefully separated from the parenchyma using a scalpel-shaped
knife (Thermo Fisher Scientific, Waltham, MA, USA). The samples obtained were then homogenized
in a blender (Sigma-Aldrich, Sintra, Portugal) and then filtered. After, the AV gel was stabilized at
65 ◦C for 15 min and stored at 4 ◦C for later use.
2.2.2. Deacetylation of Chitosan
CS was purified and deacetylated through a method previously described in the literature [21].
Briefly, 500 mg of CS LMW was dispersed in 10 mL of NaOH (1M) solution, under magnetic stirring
for 4 h, at 50 ◦C. Then, the mixture was filtered using a Whatman® quantitative filter grade 541:0.22 µm
(Sigma-Aldrich, St. Louis, MO, USA) and a Buchner funnel to recover the deacetylated CS. The
remaining material was washed extensively until the sample pH reached 7.4. Afterward, the samples
were dried at 40 ◦C overnight. The degree of deacetylation (DD) of CS was determined by using the
first derivative UV-spectroscopy (1DUVS) method [38]. UV–Vis CS spectra were acquired in a Thermo
Scientific Evolution 201 UV–Vis spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
2.2.3. Production of the Electrospun Asymmetric Membranes
A conventional electrospinning apparatus adapted by us, comprising a high voltage source
(Spellman CZE1000R, 0–30 kV) obtained from (Spellman, Corporate Headquarters USA) a precision
syringe pump (KDS-100) (acquired from Sigma-Aldrich, Sintra, Portugal), a plastic syringe with a
stainless-steel needle (21 Gauge), and an aluminum disk connected to a copper collector, was used to
produce the asymmetric membranes.
The top layer of the membrane was produced with a PCL solution (7% PCL (w/v) in 80% TFE:
20% H2O (v/v)), placed in the syringe and then electrospun at a constant flow rate of 2.5 mL/h, using
a working distance of 15 cm and an applied voltage of 25 kV. After, the top layer was produced, 10 mL
of CS_PEO solution—composed of 7% CS (w/v) and 8% PEO (w/v) (2:1 volume ratio) or CS_AV_PEO
((2:2:1 volume ratio), where an extract of 40% AV gel (v/v) was used)—was electrospun on top of
the PCL electrospun membrane at a constant flow rate of 4.0 mL/h, using a working distance of
12 cm and an applied voltage of 28 kV. The produced asymmetric membranes (PCL/CS_PEO and
PCL/CS_AV_PEO) were then characterized through in vitro assays to evaluate their suitability to be
used as wound dressings.
2.2.4. Attenuated Total Reflectance–Fourier Transform Infrared Spectroscopy Analysis
The final composition of the electrospun membranes was determined by ATR-FTIR analysis.
The membranes’ spectra were acquired with an average of 128 scans, a spectral width ranging from
4000 and 400 cm−1 and a spectral resolution of 4 cm−1, using a Nicolet iS10 FTIR spectrophotometer
(Thermo Scientific, Waltham, MA, USA). Furthermore, the spectra of the raw materials used to produce
the membranes were also acquired for comparative purposes.
2.2.5. Characterization of the Mechanical Properties of the Membranes
The mechanical properties of PCL/CS_PEO and PCL/CS_AV_PEO membranes were determined
with a Shimadzu AG-X Tensile Testing Machine (Tokyo, Japan) operated at room temperature (RT),
under wet and dry conditions, accordingly to the guidelines established by the Standard Test Method
for Tensile Properties of Polymer Matrix Composite Materials (ASTM standard D3039/ D3039 M) [15].
The tested samples (n = 5) had a width of 2 cm, a gauge length of 6 cm and a thickness ranging from
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0.41 to 0.52 mm. The length between the clamps was set to 2 cm and the speed of testing was set to
2 mm/min. In wet conditions, the membranes were immersed in a PBS solution, over 24 h at 37 ◦C.
Load-extension data was recorded and the stress–strain curve of the membranes was determined
through Equations (1) and (2), respectively:
Stress = σ =
F
A
(1)
Strain = ε =
∆l
L
(2)
where F is the applied force; A is the cross-sectional area; ∆l is the change in length, and L is the length
between the clamps.
2.2.6. Evaluation of the Porosity of the Produced Membranes
The microporosity of the membranes was determined through a liquid displacement method [25].
Briefly, three specimens were weighed and then immersed in absolute EtOH for 1 h and later on
reweighed. The membrane’s porosity was determined through Equation (3):
Porosity (%) =
Ws −Wd
Dethanol × Vmembrane × 100 (3)
where Wd is the initial weight of dry membrane and Ws is the weight of the swollen membrane,
Dethanol is the density of the ethanol at room temperature and Vmembrane is the volume of the swollen
membrane. For each sample, three replicates were used and the presented data represents the average
of the results obtained for each sample.
2.2.7. Determination of Contact Angle at the Surface of the Produced Membranes
The contact angles at the surface of the samples were determined with a Data Physics Contact
Angle System OCAH 200 apparatus (DataPhysics Instruments GmbH, Filderstadt, Germany) operating
in static mode, at 25 ◦C and using water as a reference fluid. For each sample, water drops (4 µL) were
placed on the surface of the membranes. The reported contact angles are the average of at least three
independent measurements.
2.2.8. Water Vapor Transmission Rate (WVTR)
The water vapor diffusion through the PCL/CS_PEO and PCL/CS_AV_PEO membranes was
evaluated accordingly to a method previously described elswhere [25]. Briefly, the membranes were
used to seal the opening of a glass test tube (1.77 cm2) containing 10 mL of ultrapure water to avoid
its evaporation. A parafilm tape was used to attach the membrane to the glass tube. Afterward,
the membranes were incubated at 37 ◦C and at specific time points, the amount of water evaporation
was obtained by determining the weight loss. The WVTR was estimated through Equation (4):
Water Vapor Transmission Rate =
Wloss
A
(4)
where Wloss is the daily weight loss of water and A is the area of the tube opening.
2.2.9. Swelling and Enzymatic Degradation
Swelling and degradation tests were performed by immersing all samples in PBS (pH = 5) and PBS
containing 13.6 mg/mL lysozyme, at 37 ◦C, under stirring (60 rpm) for 30 days [35]. All experiments
were conducted in triplicate and the solutions were changed periodically in order to guarantee that
the enzyme remained active through the study. The swollen sample weights were measured after
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removing the water excess present at the surface of the membranes, by gently tapping the surface with
filter paper. Water uptake was determined through Equation (5).
Swelling ratio (Q) =
Wt
W0
(5)
where Wt is the final weight and W0 is the initial weight of the membranes.
The degradation profile of the samples was determined at specific time points (1, 3, 7, 14, and
30 days). To do that, samples were removed from the solution (PBS with 13.6 mg/mL lysozyme)
and weighed, after being completely dried [38]. The degradation percentage at each time point was
calculated according to Equation (6):
Weight loss (%) =
Wi −Wt
Wt
× 100 (6)
where Wi corresponds to the initial weight of the sample and Wt to the weight of the sample at time t.
2.2.10. Protein Adsorption
To characterize protein adsorption at the surface of the membranes, Bovine Serum Albumin (BSA)
was used, following a procedure described elsewhere [39]. The membranes were initially placed in a
24-well cell culture plate and 300 µL of BSA (1 mg/mL protein/phosphate buffer) was added to the
surface of the electrospun membranes. The plate was then placed in a humidified incubator at 37 ◦C
at specific time points. Empty wells (tissue culture polystyrene (TCPS)) were used as background
reference. The non-adherent BSA was removed from wells by washing them with PBS solution.
Subsequently, 300 µL of 2% sodium dodecyl sulfate was added to each well and then incubated
overnight to extract adhered proteins. The concentration of the adhered proteins was determined
through the micro bicinchoninic acid (BCA Kit) assay.
2.3. Characterization of the Biological Properties of the Produced Membranes
2.3.1. Characterization of Cell Viability and Proliferation in Contact with the Membranes
The cytotoxic profile of produced membranes was evaluated in vitro following ISO 10993-5. Prior
to cell seeding, membranes were placed into 96-well plates and then sterilized, by UV irradiation
(254 nm, ~7 mW cm−2), over 1 h. NHDF cells were used as model and seeded at a density of
10 × 103 cells per well in the presence of the membranes. Then, the plate was incubated at 37 ◦C, in a
5% CO2 humidified atmosphere, and the culture medium was changed every two days until the end
of the assay. After 1, 3, and 7 days of incubation, a MTS assay was performed to characterize the
membranes biocompatibility. Briefly, the medium of each well was removed and replaced by a mixture
of 100 µL of fresh culture medium and 20 µL of MTS/PMS (phenazine methosulfate) reagent solution.
Following this, cells were incubated for 4 h, at 37 ◦C, in a 5% CO2 atmosphere. The absorbance of
each sample (n = 5) was determined at 492 nm using a microplate reader (Biorad xMark microplate
spectrophotometer). Cells cultured without materials were used as a negative control (K–), whereas
cells cultured with EtOH (96%) were used as positive control (K+).
2.3.2. dsDNA Quantification
To assess the cells proliferation rate, the total DNA content was measured with a Quan-iT
PicoGreen dsDNA Assay kit, following a protocol previously described in the literature [35,40].
Briefly, NHDF cells were seeded, at a density of 10 × 103 cells/mL, in contact with the produced
membranes. After 1, 3, and 7 days, the membranes were washed twice with PBS and then each
membrane was transferred into a 1.5 mL Eppendorfs containing 1mL of ultra-pure water. Thereafter,
the cell–membrane complexes were subjected to a freeze–thaw cycle and sonicated for 15 min, to lyse
the cells. Samples and standards were prepared and mixed with a PicoGreen solution at a 200:1
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ratio and placed in a 96-well plate (n = 3) [35]. The plate was incubated for 10 min in the dark and
fluorescence was measured in a microplate reader using excitation and emission wavelengths of 480 nm
and 520 nm, respectively. A calibration curve was performed and samples dsDNA concentrations
were determined.
2.3.3. Characterization of the Antimicrobial Properties of the Membranes
Analysis of Bacterial Penetration through the Top Layer of the Produced Membranes
S. aureus and E. coli, gram-positive and gram-negative bacteria, were used to characterize the
capacity of the membrane’s top layer to avoid bacterial infiltration within their structure. To accomplish
this, transwell systems (Corning Incorporated, New York, NY, USA) were modified with a PCL
membrane or a filter paper (0.22 µm) (control group) to act as the interface between the upper and
lower chamber. The PCL membrane and the filter paper were inoculated with a bacterial suspension
(1 × 108 colony forming units (CFU)/mL), during 24 h, at 37 ◦C [41]. After, the optical density of the
medium culture present in the lower chamber was determined. Posteriorly, the number of colonies
that cross the PCL membrane/filter paper were also counted. Furthermore, the PCL membrane and
filter paper were recovered and submitted to SEM analysis to evaluate the presence of the bacterial
colonies on the upper and lower side of the samples.
Characterization of Bactericidal Activity of the Bottom Layers
(CS_PEO and CS_AV_PEO) Membranes
The bactericidal activity of the PCL/CS_PEO and PCL/CS_AV_PEO membranes was also
characterized using S. aureus and E. coli as bacteria models. Briefly, each membrane was added
to 10 mL of LB broth at pH 6.2, containing 1 × 105 colony forming units (CFU)/mL of early mid-log
phase culture and then were incubated at 37 ◦C, for 24 h. After the incubation period, serial dilutions
were prepared and 100 µL of bacterial samples were transferred into LB agar plates. Following
overnight incubation at 37 ◦C, bacterial colonies were counted and expressed as the number of colonies
forming units per mL [25,42,43]. The bacterial growth inhibition was calculated through Equation (7):
Antibacterial efficiency (%) =
N0 − N
N0
× 100 (7)
where N0 and N each represents the bacteria number of control and experimental group.
To further characterize the bactericidal activity of the membranes, biofilm formation on the
membrane’s surface was also studied. To accomplish this, the produced membranes were placed on
the surface of a plate of LB agar in contact with S. aureus and E. coli (1 × 108 colony forming units
(CFU)/mL) and then incubated for 24 h, at 37 ◦C [21]. Following this, biofilm formation at the surface
of the membranes was assessed through SEM analysis.
2.3.4. Characterization of the Morphologic Features and Biological Performance of the Electrospun
Membranes by SEM Analysis
Biological samples, containing cells or bacteria, were fixed for 4h with 2.5% (v/v) glutaraldehyde.
Following this, samples were washed three times with PBS and then dehydrated with growing
concentrations of EtOH (70%, 80%, 90%, and 100%) or freeze-dried for 3 h. Finally, all biological and
non-biological samples were mounted onto aluminum stubs with Araldite glue and sputter-coated
with gold using a Quorum Q150R ES sputter coater (Quorum Technologies Ltd, Laughton, East Sussex,
UK). SEM images were then acquired with different magnifications, using an acceleration voltage of
20 kV, in a Hitachi S-3400N Scanning Electron Microscope (Hitachi, Tokyo, Japan).
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2.3.5. Confocal Microscopy Analysis
Confocal laser scanning microscopy (CLSM, Zeiss, Oberkochen, Germany) was used to
characterize cell distribution and proliferation at the surface of both layers of the produced asymmetric
membranes. Cells (10 × 103 cells/mL) were seeded on the surface of CS_PEO and CS_AV_PEO layers,
which were previously placed in µ-Slide 8 well Ibidi imaging plates (Ibidi GmbH, Planegg/Martinsried,
Germany). After 1 and 3 days, cells were fixed with 4% paraformaldehyde (PFA) in PBS for 20 min
and then stained with the WGA-Alexa 594® conjugate. Cells were then rinsed several times with PBS
and labeled with Hoechst 33,342® nuclear probe (2 µM). The 3D reconstruction and image analysis
were performed using Zeiss Zen 2010 software (Zeiss, Oberkochen, Germany).
2.4. Statistical Analysis
The statistical analysis of the results obtained was performed using one-way analysis of variance
(ANOVA), with the Newman-Keuls post hoc test. A p value lower than 0.05 (p < 0.05) was considered
statistically significant.
3. Results and Discussion
3.1. Characterization of the Morphology of the Membranes
When asymmetric membranes are aimed to be used as wound dressings, they are conceived with
a dense top layer, that can protect the wound from physical damage and infection, and a porous and
hydrophilic inner layer capable of absorbing the wound exudate and providing a 3D architecture that
enables cell adhesion and proliferation [44].
Up to now, different techniques have been used to produce these membranes, including
supercritical carbon dioxide (scCO2)-assisted phase, dry/wet-phase inversion, and electrospinning [10,45].
In this study, asymmetric membranes were produced with an electrospinning apparatus. In Figure 1,
a denser top layer can be observed that was manufactured with PCL (an FDA-approved biomaterial
that has a low cost, is biocompatible, and displays good mechanical properties) [16,46–48]. This
polymer confers to the top layer suitable mechanical properties, waterproof capacity, avoids
bacteria penetration, and regulates the gaseous exchanges between the wound and the surrounding
environment. On the other hand, the porous bottom layer was composed either of CS_PEO or
CS_AV_PEO and was designed to be able to absorb the wound exudates, promote nutrient exchange,
support cell proliferation, and also to confer antimicrobial properties to the membrane. The higher
porosity of the bottom layers of the asymmetric membranes was also confirmed by the results obtained
in porosity assays (see further details in Section 3.4).
Regarding the macroscopic images (insets of Figure 1), it is possible to identify the two different
layers of asymmetric membrane. Such a feature will make easier the future application of the
membranes at the wound site.
The diameter of the electrospun nanofibers present in the membranes was determined through
SEM analysis (Figure 2). The top layer displays randomly oriented fibers with average diameters of
385 ± 134 nm. Such a result is in agreement with the data available in the literature for membranes
produced with PCL [49]. In turn, the bottom layer of membranes presented a mean diameter of
239 ± 122 nm and 152 ± 54 nm for CS_PEO and CS_AV_PEO, respectively (Figure 2). It seems that
the incorporation of the AV gel leads to the production of thinner fibers, due to the reduction of the
viscosity of the solution used for nanofiber production. Suganya and their collaborators had already
reported a similar effect on the diameter of PCL nanofibers when AV was added to the PCL solution.
Nanofibers with a diameter of the 215 ± 63 nm were produced when AV and PCL were blended [36].
On the other hand, Karuppuswamy et al. previously obtained PCL nanofibers with diameters of
346 ± 63 nm and PCL/AV nanofibers with diameters of 307 ± 42 nm [50].
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Moreover, the diameters of nanofibers produced herein are within the size range displayed
by collagen fibers present in natural ECM (50–400 nm). The increased roughness presented by the
produced membranes leads to a higher surface area available for cell adhesion. In addition, the high
porosity exhibited by the nanofibers is fundamental in preventing fluid accumulation, enhance oxygen
permeation, and ultimately improve cell adhesion and proliferation [51–53].
3.2. Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopic Analysis
The acquired ATR-FTIR spectra of raw materials and of the produced membranes are presented
in Figure 3. The spectrum of the top layer (Figure 3A) presents its characteristic peaks at 2942 cm−1
(I) (asymmetric CH2 stretching), 2868 cm−1 (symmetric CH2 stretching), 1723 cm−1 (II) (carbonyl
stretching), 1292 cm−1 (C-O and C-C stretching), 1239 cm−1 (asymmetric C-O-C stretching) and
1161 cm−1 (symmetric C-O-C stretching) [54,55].
In Figure 3B, it is possible observe the characteristic bands of PEO in the region between 2900 cm−1
and 2850 cm−1 (CH2 (band I)) [56]. Furthermore, the spectrum of the CS_AV_PEO layer (Figure 3B)
displays the characteristic peaks of AV at 1714 (O-acetyl esters (band II)), 1592 (asymmetrical COO−
stretching (band III)), 1246 (glucan units), 1030 (glycosidic bond), and 606 cm−1 (C–H ring vibration).
Additionally, the bottom layer also exhibits peaks at 2876 cm−1 (aliphatic C–H stretch), 1586 cm−1
(NH2 stretch), 1372 cm−1 (–C–O stretching of the primary alcohol group) and at 1028 cm−1 (C–O–C
glycosidic bond (band IV)) that belong to CS [57,58].
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3.3. Characterization of Mechanical Properties of the Membranes
Membranes to be used as wound dressings must present mechanical properties that can support
angiogenesis, the lymphatic system, nerve bundles, and other structures found in native skin [59–61].
Herein, the mechanical properties of the produced membranes were evaluated in dry and wet
conditions [62].
Through the analysis of the stress-strains curves (Figure 4), it is possible to notice that the
membranes display a two stage fracture in the dry state. Such a result is explained by the presence
of natural polymers (CS and AV) in the bottom layer that have weaker mechanical properties. In the
wet state the membranes do not show the two stage break, since CS and AV are less brittle in wet
conditions [15,63].
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Figure 4. Typical stress-strain curves and mechanical properties determined for the produced
membranes in dry and wet conditions. Young´s modulus, tensile strength, and elongation at break of
PCL/CS_PEO and PCL/CS_AV_PEO membranes.
PCL/CS_PEO membranes presented a Young Modulus of 46.89 ± 3.78 MPa in dry state, whereas
in wet conditions a value of 22.76 ± 2.17 MPa was obtained (Figure 4). Such increase in the elasticity
was also observed for PCL/CS_AV_PEO membranes, i.e., 36.53 ± 1.29 MPa and 27.14 ± 3.56 MPa for
the dry and wet state, respectively. Moreover, in the wet state, the PCL/CS_PEO and PCL/CS_AV_PEO
membranes displayed tensile strengths of 9.40 ± 2.40 MPa and 6.23 ± 0.33 MPa, respectively. On the
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other hand, in the dry state, the PCL/CS_PEO and PCL/CS_AV_PEO membranes presented tensile
strengths of 9.48 ± 0.55 MPa and 6.39 ± 2.09 MPa, respectively. The elongation-to-break assays
revealed that PCL/CS_PEO and PCL/CS_AV_PEO membranes can bear a strain of 26.90 ± 3.99%
and 20.98 ± 0.39% for the wet state and 38.24 ± 5.32% and 37.09 ± 0.35% for the dry state,
correspondingly. Despite the samples presenting a different behavior in dry and wet conditions,
the produced membranes show a Young modulus, tensile strengths, and elongation-to-break values
that are very close to that displayed by native skin (Young modulus (4.6–20.0 MPa), tensile strengths
(5.00–30.00 MPa) and elongation-to-break (35.00–115.00%)).
This emphasizes the suitability of the produced membranes to confer adequate mechanical
support during the tissue remodeling process, as well as, avoiding possible side effects resulting
from the stress-shielding mechanism [60,64]. The excellent mechanical performance of the produced
membranes can be explained by the presence of PCL within the top layer. In the literature, it has been
widely described that this synthetic polymer is capable of providing enhanced mechanical properties
due to its chemical and thermal stability [65,66].
3.4. Characterization of Membrane Porosity
In the area of tissue engineering, the porosity of a material is essential to provide void spaces
for cell accommodation, migration and also for the exchange of nutrients between the 3D construct
and the surrounding environment [50]. Herein, a liquid displacement method was used to determine
membrane porosity (ethanol was used as displacement fluid) [67]. The data obtained is presented in
Figure 5A and reveals that top layer (PCL) displays the lowest porosity (55 ± 5%), which is essential
for avoiding microorganism penetration [15,41]. On the other hand, the bottom layers, composed of
CS_PEO or CS_AV_PEO, showed porosities of 89.5 ± 5.3% and 97.8 ± 4.5%, respectively. Such results
can be explained by the higher number of spaces available between the CS_AV_PEO nanofibers, which
have a lower diameter.
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Several researchers have previously highlighted that materials with porosities above 90% are the
most appropriate for skin tissue engineering applications since they are able to provide the required
space for cell accommodation, migration, nutrient exchange, and production of a new ECM [46,68–72].
3.5. Membrane Surface Wettability
Material surface wettability is a crucial parameter that affects cell adhesion, proliferation, and
differentiation [73]. The surface wettability is usually characterized by determining the water contact
angle (WCA) [74–76]. In the literature, it is described that cells are more prone to adhere, spread, and
grow on moderate hydrophilic substrates (40◦ < WCA < 70◦) than on hydrophobic (WCA > 90◦) or
very hydrophilic ones (WCA < 20◦) [21,77,78].
In the present study, the membranes’ top layer exhibited a hydrophobic character (WCA
of 126.2◦ ± 1.21◦), due to the presence of aliphatic polyester PCL [79,80]. Conversely, CS_PEO
and CS_AV_PEO layers presented WCA values of 75.58◦ ± 12.57◦ and 69.06◦ ± 3.78◦ which are
characteristic of moderate hydrophilic materials. Such WCA values can be explained by the presence
of natural polymers (CS and AV) that have functional groups like amides, esters, and hydroxyl groups
which confer hydrophilic character to the bottom layer [81,82]. During the wound healing process,
hydrophilic materials are able to provide moist environments, that enhance the healing process [83].
3.6. Water Vapor Transmission Rate
As described above, an ideal wound dressing besides providing a moist environment, must
also avoid wound dehydration, as well as be capable of removing the wound exudate [15,21,43].
An accumulation of exudate at the wound site leads to the breakdown of extracellular matrix
components or to the maceration of the healthy surrounding tissues, that ultimately induces more pain
to the patient [84].
Furthermore, it has been reported that wound dressings with WVTRs values ranging from
2000–2500 g/m2/day provide an adequate level of moisture and prevent exudate accumulation [85].
Here, the produced membranes showed similar WVTR values: The PCL/CS_PEO membrane
displayed a WVTR of 1452.61 ± 86.08 g/m2/day, while the PCL/CS_AV_PEO had a value of
1252.35 ± 21.22 g/m2/day. Although the determined WVTR values are outside the range of that
displayed by an ideal dressing, there are several commercially available wound dressings that
have WVTR values outside this range, like Tegaderm (3M, Maplewood, MN, USA), Bioclusive
(Johnson-Johnson, New Brunswick, NJ, USA), and Op Site (Smith & Nephew, London, UK), which
have WVTRs of 491 ± 44, 394 ± 12, and 792 ± 32 g/m2/day, respectively [86–89].
3.7. Characterization of the Membranes’ Swelling Profile
The characterization of the swelling profile of the membranes is fundamental to evaluate the
capacity of these membranes to absorb the wound exudate. To accomplish that, membranes were
incubated in a PBS solution and their weight was monitored at specific timepoints. The obtained
results showed that the PCL/CS_AV_PEO membrane displays a higher water absorption ratio (~20)
than the PCL/CS_PEO membrane (~10) (Figure 5B). Such a result is explained by the incorporation of
hydrophilic materials in the composition of membranes [21,31,34,35]. Furthermore, the swelling profile
displayed by the membranes is compatible with the removal of the excess of exudate from the wound,
which is usually produced during the inflammatory phase of the healing process (1–3 days after the
injury occurs). Based on this data, the PCL/CS_AV_PEO membranes are the ones more appropriate to
absorb any excess of exudate that may be present in the wound.
3.8. Characterization of Degradation Profile of the Membranes
Commercially available wound dressings are usually non-degradable and they need to be
removed from the wound. Such removal can affect the healing process since it can induce the formation
of scar tissue as well as increase the risk of bacterial contamination [78,90]. To overcome this drawback,
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researchers started to produce biodegradable wound dressings. However, their rate of degradation
must be proportional to the rate of healing or regeneration of the compromised tissue [91,92]. Herein,
the degradation profile of the developed membranes was studied using lysozyme, an enzyme found in
human serum, which is capable of degrading CS-based materials in vivo [93,94]. The results obtained
revealed that after 30 days of incubation, the PCL/CS_AV_PEO and PCL/CS_PEO membranes had
weight losses of ~30% and ~10%, respectively (Figure 5C). Such variation in weight is explained by AV
capacity to reduce the number of interactions occurring between CS molecules, thus facilitating the
enzymatic degradation [35].
Despite PCL displaying a slow degradation profile in vitro [79], it is expected that under
in vivo conditions it degrades faster. A variety of enzymes, like matrix metalloproteinase (MMP-1),
gelatinase-A (MMP-2), and stromelysin-1 (MMP-3) are secreted by macrophages, epidermal cells, and
fibroblasts during the wound healing process and may contribute to the enzymatic breakdown of
PCL [95–97].
3.9. Evaluation of Protein Adsorption on the Membranes’ Surface
When a wound dressing is placed at the wound site, it is exposed to body fluids and almost
immediately proteins present in these fluids become adsorbed onto the dressing’s surface. Protein
adsorption can have a direct impact on the material’s biocompatibility since it can influence cellular
attachment [76,98,99]. Indeed, cells adhere to proteins adsorbed on material surfaces through
membrane receptors that recognize specific amino acid sequences present in adhesive proteins
(e.g., fibronectin, and vitronectin) [100]. Herein, to characterize protein adsorption to the PCL,
PCL/CS_PEO and PCL/CS_AV_PEO membranes´ surface, albumin was used as a model protein
(Figure 5D). Albumin is the most abundant protein in serum and after an injury occurs this protein
is accumulated at the wound site, during the early phase of the healing process. Subsequently,
the absorbed albumin is replaced by fibronectin and vitronectin [76]. The results obtained revealed
that albumin did not become adsorbed onto the PCL membrane (Figure 5D), as previously reported
in the literature [101,102]. Conversely, the concentration of protein adsorbed onto PCL/CS_PEO
and PCL/CS_AV_PEO membranes increases with time and no statistically significant difference was
noticed between these samples. Such a finding was expected since both membranes exhibit rough,
porous and hydrophilic surfaces (WCA < 90◦). Furthermore, other authors claim that the protein
adsorption at the membranes’ surface can occur through the interaction of proteins with the amine
groups of CS, which have a high affinity for negatively charged groups found on proteins and cell
membranes [103–105].
3.10. Evaluation of Cell Viability and Proliferation in the Presence of Membranes
The wound healing process is known by its complexity and interaction of different cell types with
matrix components that act together to re-establish the 3D structure and the functions of the damaged
tissue. Herein, NHDF cells, enrolled in the synthesis of collagen, fibronectin, and other biomolecules
were used to evaluate the cell response to the presence of the developed membranes [106].
Optical microscopic images of the NHDF cells in contact with membranes after 1, 3, and 7 days
are presented in Figure 6. These images show that NHDF cells did not suffer any morphological
variation when in contact with the membranes, displaying a similar shape to those of K−, where cells
were incubated with culture medium.
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of incubation; K− (negative control); K+ (positive contr l).
Moreover, the cytotoxic profile of the membranes was evaluated through an MTS assay, over 1, 3,
and 7 days (Figure 7A). The results revealed that all membranes did not induce any cytotoxic effect on
NHDFs, over 7 days. Furthermore, the dsDNA quantification results (Figure 7B) are compliant with
the data obtained in the MTS assay, suggesting that NHDFs remain viable and proliferate over at least
7 days, when they are seeded in contact with the produced membranes.
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unknown. Previous studies speculated that AV interacts with the growth factor receptors of the 
fibroblasts and stimulates cell activity and proliferation [36,109]. Such interaction occurs between the 
active components, such as mannose-6-phosphate and/or acemannan, present in AV and the 
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Figure 7. Characterization of the biological performance of the produced membranes. NHDF cell
viability was evaluated when the cells were incubated with produced membranes (A) and the content
of dsDNA of NHDF cells adhered to the surface of the developed membranes was determined after
1, 3, and 7 days of incubation. The statistical analysis of the results was performed using one-way
ANOVA with Newman–Keuls test (B); SEM micrographs of NHDF cells morphology at the surface of
the different electrospun membranes after 1, 3, and 7 days are presented in (C).
Besides being biocompatible, a wound dressing must also promote cell attachment, growth, and
proliferation. Herein, the cell adhesion to the surface of the membranes was characterized by SEM
analysis (Figure 7C). The obtained SEM images evidenced the bioadhesive character of the bottom
layer of the produced membranes.
After 7 days of incubation, it was possible to visualize that cells adhere and proliferate on the
nanofibrous network, which is crucial for tissue regeneration [107]. Additionally, CLSM analysis
was also performed and the acquired images (Figure 8) demonstrate that, after 3 days of incubation,
the fibroblast cells have a higher attachment, proliferation, and growth when they are in contact with
the PCL/CS_AV_PEO membranes, in comparison to the PCL/CS_PEO ones. Similar results have been
already reported for other materials that have AV in their composition [108]. The exact mechanisms
through which AV stimulates cell proliferation and growth factor production in fibroblasts are still
unknown. Previous studies speculated that AV interacts with the growth factor receptors of the
fibroblasts and stimulates cell activity and proliferation [36,109]. Such interaction occurs between the
active components, such as mannose-6-phosphate and/or acemannan, present in AV and the mannose
receptor available on the fibroblast’s surface [110,111]. The results obtained through the color coded
depth analysis of the membranes showed that fibroblasts migrate to the interior of the membrane,
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with some cells being observed between 8–10 µm within the polymeric structure, after 3 days of
incubation (Figure 8). Such data emphasize that the pores available on the bottom layers allow cellular
internalization, and also provide an effective nutrient supply and metabolic waste removal, thus
leading to the restoring of the structure and functions of the native tissue [21,112].
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The results presented in Figure 9 show that the top layer of the produced membranes acts as 
protective barrier, avoiding the infiltration of the model bacteria. The data obtained for this layer 
does not show any significant statistical difference with the control group, where filter paper (with 
pore size of 0.22 μm) was used. SEM images also evidenced that few bacteria were able to adhere to 
the upper side of the top layer. Such results can be explained by the low porosity of the PCL layer, 
that hampers the entrance of microorganisms into the wound.  
i re 8. Confocal laser scanni g microscopy (CLSM) images of fibroblast cells cultured on the surface
of CS_PEO and CS_AV_PEO layers and color coded depth analysis (red 0 µm, blue 10–14 µ ) after
and 3 days. Blue channel: cell nuclei label d Hoechst 33342®; red channel: cytopl sm stained with
WGA-Alexa 594® conjugate.
3.11. Characterization of the Antimicrobial Properties of the Produced embranes
Skin injuries are prone to icroorganis conta ination, that can often interrupt the healing
process and lead to life-threatening complications. Such are the demands for wound dressings capable
of avoiding bacterial invasion and growth. In this study, the antimicrobial properties of the produced
membranes were characterized by using S. aureus (gram-positive bacterium) and E. coli (gram-negative
bacterium) as models [113,114].
The results presented in Figure 9 show that the top layer of the produced e branes acts as
protective barrier, avoiding the infiltration of the model bacteria. The data obtained for this layer does
not show any significant statistical difference with the control group, where filter paper (with pore size
of 0.22 µm) was used. SEM images also evidenced that few bacteria were able to adhere to the upper
side of the top layer. Such results can be explained by the low porosity of the PCL layer, that hampers
the entrance of microorganisms into the wound.
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environment at the wound site was also evaluated. To accomplish this, membranes were incubated 
over 24 h with bacteria. Both bottom layers (CS_PEO and CS_AV_PEO) showed an inhibitory effect 
on S. aureus and E. coli growth (see Figure 10A,B). Furthermore, no biofilm formation on the 
membrane’s surface was noticed (see Figure 10C for further details) due to the intrinsic bactericidal 
activity of CS and AV. 
Figure 9. Evaluation of the bacterial infiltration through PCL membrane and filter paper (control
group). The optical density of the medium culture present in the lower chamber of the transwell system
determined at 600 nm is shown in (A); The number of colony forming units of S. aureus and E. coli that
cross the PCL and filter paper, after 24 h, are displayed in (B); SEM images of adhered microorganisms
(S. aureus and E. coli) at the upper and lower side of the PCL membrane and filter paper are observed
in (C).
Additionally, the capacity of the bottom layers (CS_PEO and CS_AV_PEO) to provide an aseptic
environment at the wound site was also evaluated. To accomplish this, membranes were incubated
over 24 h with bacteria. Both bottom layers (CS_PEO and CS_AV_PEO) showed an inhibitory effect on
S. aureus and E. coli growth (see Figure 10A,B). Furthermore, no biofilm formation on the membrane’s
surface was noticed (see Figure 10C for further details) due to the intrinsic bactericidal activity of CS
and AV.
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Figure 10. Evaluation of the bactericidal activity of the produced membranes. The antibacterial activity
of PCL/CS_PEO and PCL/CS_AV_PEO membranes against S. aureus and E. coli is presented in (A,B),
respectively; SEM images of S. aureus and E. coli in contact with PCL/CS_PEO and PCL/CS_AV_PEO
membranes and of the negative controls are displayed in (C).
In the literature, it has been described that this polycationic polymer interacts with the negatively
charged groups present at the bacteria surface, leading to an increased cell wall permeability and
consequently the leakage of intracellular constituents and the dissipation of the ionic gradients that
exist in bacteria [21,115–117]. Furthermore, the positive charge density can be increased through a
deacetylation process. Herein, the chitosan deacetylation degree was set to about 98% (see Table 1),
i.e., almost all the primary amine groups of CS were positively charged and are available to interact
with the negatively charged groups present in the bacterial cell wall. Additionally, the acemannan,
anthraquinones, and salicylic acid present in AV gel also contribute to the bactericidal activity displayed
by the produced membranes [35,118].
Table 1. Degree of deacetylation of the different chitosan samples used in this study (n = 3).
Sample Nominal DD a (%) Determined DD b (%)
(1) Comercial Chitosan 75–85 82.02 ± 1.87
(2) Purified Chitosan — 97.88 ± 1.19
a Provided by the manufacturer; b Determined by first derivative UV-spectroscopy (1DUVS).
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4. Conclusions
In this study, electrospinning technology was used to produce asymmetric membranes composed
of PCL, CS, PEO and in some cases AV. The asymmetric structure of the membranes was conceived to
mimic skin native structure. The top layer confers protection to the wound against external threats
and, simultaneously, the bottom layer encourages cell migration and proliferation. The results attained
show that the incorporation of AV in a CS_PEO nanofiber system enabled the production of a bottom
layer capable of providing adequate moisture at the wound site as well as promoting better and faster
fibroblast attachment and proliferation. In addition, the produced membranes presented mechanical
properties and antimicrobial activity that are compatible with their applications as wound dressings.
In the near future, the incorporation of other bioactive molecules (e.g., ECM components,
vitamins or growth factors) can be considered as a means to further improve the performance of
these membranes in wound repair or other envisioned biomedical applications.
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